Amyloidosis — Trials · CancerIndex

Clinical trials

Registered studies

47 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 6
Recruiting: 5
Ph III recruiting: 0
Growth YoY: —
Industry share: 33%
Top sponsor: Alexion Pharmaceuticals, Inc.
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (2)

clinicaltrialsPublishedShowing 1–4 of 4 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05260203	MargheRITA (Remote Intelligence for Therapeutic Adherence)(MargheRITA)	completed	N/A	124	Advice Pharma Group srlINDUSTRY	1	Nov 6, 2024	clinicaltrials
NCT02158052	Combined Bone Marrow and Renal Transplantation for Hematologic Disorders With End Stage Renal Disease	completed	N/A	2	Massachusetts General HospitalOTHER	1	Dec 13, 2022	clinicaltrials